Launch HN: Iollo (YC S22) – At-home metabolomics test to extend healthy lifespan

Re:Launch HN: Iollo (YC S22) – At-home metabolomics test to ... by hn_throwaway_99 on Wednesday August 03, 2022 @12:54PM (#32334141)

In 2013 FDA shut down 23andMe's direct-to-consumer reports because they said consumers would misunderstand genetic information and "self treat". FWIW I thought this was a dumb decision and feel lucky that I was grandfathered in to some helpful reports before the FDA put the kibosh on them.

Do you think this is a risk to you? How will you deal with the FDA?

[ Parent | on HN ]

Re:Launch HN: Iollo (YC S22) – At-home metabolomics test to ... by danielgomari on Wednesday August 03, 2022 @01:40PM (#32334720)

In general, it's good that the FDA is holding companies to a certain standard. We're currently running our tests under an IRB and this is actually one of the first steps for us to have enough data to start our application to the FDA.

[ Parent | on HN ]